共 50 条
- [41] Re: Association of Metabolic Syndrome and Benign Prostatic Hyperplasia in Chinese Patients of Different Age Decades Editorial CommentJOURNAL OF UROLOGY, 2015, 194 (04): : 1055 - 1055Kaplan, Steven A.
- [42] Circadian Rhythm of Blood Pressure in Patients With Benign Prostatic Hyperplasia Editorial CommentJOURNAL OF UROLOGY, 2009, 181 (04): : 1804 - 1805Turgut, F.Bayrak, O.Kanbay, M.Ozkara, A.Uz, E.Bavbek, N.Kargili, A.Akcay, A.
- [43] Re: Prescriber Monitoring for Benign Prostatic Hyperplasia Within a Family Medicine Clinic: A Comparison of Medication Classes Editorial CommentJOURNAL OF UROLOGY, 2013, 189 (04): : 1450 - 1450Kaplan, Steven A.
- [45] Re: Transurethral Ethanol Ablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: Long-Term Follow-Up Editorial CommentJOURNAL OF UROLOGY, 2012, 187 (01): : 211 - 212Kaplan, Steven A.
- [46] Re: Prevalence of Inflammation and Benign Prostatic Hyperplasia on Autopsy in Asian and Caucasian Men Editorial CommentJOURNAL OF UROLOGY, 2016, 195 (04): : 1042 - 1042Kaplan, Steven A.
- [47] Re: Impact of Metabolic Syndrome on Response to Medical Treatment of Benign Prostatic HyperplasiaJOURNAL OF UROLOGY, 2016, 195 (05): : 1545 - 1545Kaplan, Steven A.
- [48] Urodynamic and clinical effects of terazosin therapy in patients with symptomatic benign prostatic hyperplasiaJOURNAL OF UROLOGY, 1996, 155 (04): : 1317 - 1323Witjes, WPJRosier, PFWMdeWildt, MJAMvanIersel, MPDebruyne, FMJdelaRosette, JJMCH
- [49] An open study of the efficacy, safety and tolerability of Doxazosin in the symptomatic treatment of benign prostatic hyperplasia 6TH CONGRESS OF THE MEDITERRANEAN UROLOGICAL ASSOCIATION, 1999, : 37 - 46
- [50] Re: Does Benign Prostatic Hyperplasia Treatment with Alpha-Blockers Affect Prostate Cancer Risk? Editorial CommentJOURNAL OF UROLOGY, 2013, 190 (06): : 2096 - 2096Kaplan, Steven A.